An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Clinical trial NCT02589717 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT02589717
- Sponsor
- Genentech, Inc.
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
- Start date
- 2015-11-01
- Primary completion
- 2016-08-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.